The Association Between Vitamin D Deficiency and COVID-19 Severity in Prisma Health Patients


Background/Knowledge Gap: The novel pandemic viral disease COVID-19, caused by the coronavirus Sars-CoV-2, causes extensive morbidity and mortality. As there is no proven treatment, the study of immunoprotective factors is critical. Vitamin D, is an essential vitamin with immunoprotective, anti-microbial, and anti-inflammatory properties. Vitamin D is thought to modulate components of the immunological surge associated with severe COVID-19. Thus, we hypothesize that vitamin D deficiency modulates the presentation, course, and outcome of COVID-19 patients.

Methods/Design: This retrospective cohort study examines the correlation between COVID-19 disease severity and historical vitamin D levels. The primary outcome is disease severity, quantified as the worst daily score from each patient’s daily World Health Organization Clinical Progression Scale. This scale stratifies disease severity by factors such as hospitalization, need for supplemental oxygenation, laboratory values that reflect oxygen delivery, and use of physiological replacement technologies such as mechanical ventilation and dialysis. Secondary outcomes include the number of emergency department visits, Emergency Severity Index at presentation for ED patients, and length of stay. We will use historical vitamin D levels obtained in the 3 years before COVID-19 testing to identify probable vitamin D deficiency and insufficiency. We will use multivariable logistic and linear regression models to analyze retrospective data abstracted from the Prisma Health Rapid Innovation Task Force COVID-19 Registry to control for age, race, sex, smoking history, comorbidities, and presentation site as well as seasonality of prior vitamin D testing.

Conclusions/Implications: We propose that optimizing vitamin D levels will improve patient outcomes, particularly in the underserved communities most likely to suffer vitamin D deficiency. This pivotal research will clarify the effect of vitamin D deficiency on COVID-19 disease severity, establish a foundation for further study of vitamin D supplementation in COVID-19 patients, and advance understanding of the pandemic disease COVID-19.


Read Complete Article Here:

See Full Article



CAPS(Caribbean American Professional Society)

Dr. Walker

® & ©

Inc. All Rights Reserved.

Dr. Walker’s Advice

Parenting

Weight Management

COVID-19 Support

Contact Dr. Walker

Contact Us

Educational Mission Trip

Legal

Advertise with Us

Privacy Policy

Terms of Use


Affiliate Links

Globotrax

Christiana Gordon

Hampton Roads Ultrasound

Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The contents of this website are based upon the views of Dr. Walker and his experience. This product is not intended as medical advice nor to diagnose, treat, cure or prevent any disease. The information is likewise not to replace the advice of a qualified health care provider. The information provided herein is intended as a sharing of general knowledge only and is not intended to be, nor is it, medical advice or a substitute for medical advice. That being said, please consult your healthcare provider before using supplements or providing supplements to children under the age of 18. If you have or suspect you have, a specific medical condition or disease, please consult your healthcare provider.

© Dr. Dennis D. Walker . All Rights Reserved